Hannah Slater

ASCO named the advance in their annual report, Clinical Cancer Advances: ASCO’s Annual Report on Progress Against Cancer, highlighting novel advances and listing research priorities for the cancer community.

Researchers indicated that using observed incidence rates from patients with colorectal cancer alone to assess potential screening outcomes may underestimate cancer prevention benefits.

Inconsistencies observed by researchers on these websites indicated that efforts are needed to improve website content and readability.

Delivering the PDA to clients of tobacco quit lines, researchers highlighted the importance of broader dissemination and greater effect of the intervention.

Across all oncologic procedures observed in this study, the robotic approach was found to be most associated with lower out-of-pocket costs.

For the first time in 50 years, the government agency is examining asbestos testing for talc powders and cosmetics after traces of the known carcinogen were found in a number of such products.

Researchers found that through inheritable changes of gene expression, chronic exposure to IL-1β can promote lung cancer metastasis, without altering DNA sequence.

The O-RADS MRI tool could potentially reduce unnecessary or over-extensive surgery in patients with various types of ovarian cancer.

The data was presented at the EHA-EBMT 2nd European CAR T-Cell Meeting, which took place on January 30, 2020 in Barcelona, Spain, and showed encouraging signs of a manageable safety profile in adults with relapsed/refractory DLBCL.

The phase I trial is evaluating cobomarsen in cancers where the disease process appears to be correlated with an increase in miR-155 levels, including adult T-cell leukemia/lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia.

The expert spoke about the best way for physicians to discuss biomarker testing with their patients to ensure that they have an understanding and can make the right decisions for their treatment.

This study found that men with low baseline PSA levels could be screened less frequently, while men with higher baseline levels would benefit from more intensive screening strategies.

This suggestion is based on statistically significant distinctions observed in survival rates of patients with single hormone receptor-positive breast cancer vs double hormone receptor-positive/double hormone receptor-negative breast cancer.

Given these data, the researchers indicated that physicians screening for this cancer type should account for strong age dependence.

According to researchers, when individuals quit smoking it not only stops further damage from accruing, but it also may lead to the reawakening of cells that were not damaged by tobacco carcinogens.

This large meta-analysis was found to support the GCIG Fifth Ovarian Cancer Consensus statement that OS is the preferred primary end point.

MBI-LCBI, with the addition of any bloodstream infections, was associated with significant morbidity and mortality in this patient population.

Postmenopausal women who had low perceived social support before their diagnosis had higher overall and CRC-specific mortality in this study.

The investigation of darolutamide plus ADT in men with non-metastatic castration-resistant prostate cancer indicated a significant improvement in overall survival in this patient population.

Regardless of these improvements though, researchers noted that cancer survivors remain at risk for shorter lifespans, particularly when radiotherapy was utilized as a part of their childhood cancer treatment.

Patients with head and neck cancer saw better overall survival when treated at academic comprehensive cancer programs and integrated network cancer programs, compared to comprehensive community cancer programs and community cancer programs.

The perceptions, which were associated with worry and a decreased quality of life, indicated the need for patient education that is suitable for diverse populations and improved risk communication by physicians.

The ALL expert spoke about new research in the field and how it has changed the landscape for this disease.

This study suggested that along with pelvic floor underactivity, men who had a prostatectomy and experienced stress urinary incontinence as a result have pelvic floor overactivity as well.

The combination of talimogene laherparepvec and pembrolizumab was associated with antitumor activity across a range of sarcoma histologic subtypes in this phase II clinical trial.

This is the first cost-effectiveness analysis of the agent compared with the current standard of care using a constructed population-based control arm.

The company’s application is based on results from the phase III IMbrave150 study of the regimen for the treatment of patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.

The dual PI3K/mTOR inhibitor LY3023414 also displayed moderate single-agent activity in this study of patients with heavily pretreated advanced endometrial cancer.

Researchers noted that these findings do not indicate that insurance alone will eliminate racial and ethnic disparities in breast cancer; however, it is one systemic change that may ameliorate consistent disparities.

Researchers have yet to determine the optimal use of the AI system, though assessments in the clinical setting indicated that the technology could enhance screening results, potentially identifying breast cancer earlier than the standard of care.